FDA Approves First Medicine for Obstructive Sleep Apnea - The Jewish Press
FDA approves Zepbound, first medication for moderate to severe obstructive sleep apnea in obese adults, to be used with diet and exercise. Zepbound, also known as Mounjaro, reduces appetite and improves OSA by reducing body weight, with significant reduction in apnea/hypopnea events and weight loss in studies.
Highlighted Terms
Related News
FDA Approves First Medicine for Obstructive Sleep Apnea - The Jewish Press
FDA approves Zepbound, first medication for moderate to severe obstructive sleep apnea in obese adults, to be used with diet and exercise. Zepbound, also known as Mounjaro, reduces appetite and improves OSA by reducing body weight, with significant reduction in apnea/hypopnea events and weight loss in studies.